- cafead   Oct 27, 2023 at 11:42: AM
via Sanofi has reported setbacks to a trio of candidates bought in by its business development team, halting work or posting negative data on assets picked up from Denali Therapeutics, Kymab and Principia Biopharma.
article source
article source